MedTrace Logo

The Effect of Losartan on Emotional Processing in Healthy Volunteers

NCT03434054 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2018-02-19

No results posted yet for this study

Summary

This experimental medicine study explores whether a single dose of losartan (50mg) versus placebo affects the processing of positive and negative stimuli, using fMRI.

Conditions

  • Healthy Volunteers

Interventions

DRUG

Losartan

blood pressure medication

OTHER

Placebo

non-active sham intervention

Sponsors & Collaborators

  • University of Oxford

    lead OTHER

Principal Investigators

  • Andrea Reinecke, PhD · University of Oxford

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-06-01
Primary Completion
2017-06-30
Completion
2017-06-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03434054 on ClinicalTrials.gov